Successful case of olaparib treatment for castration-resistant prostate cancer with multiple DNA repair gene mutations: Use of comprehensive genome profiling for treatment-refracto... by Yukiyoshi Hirayama, Minoru Kato, Kaoru Kimura, Taiyo Otoshi, Takeshi Yamasaki, Junji Uchida

Subjects: Get full text

The progress and prospect of homologous recombination deficiency detection in clinical diagnosis and treatment of cancer by YU Li , SHEN Minna , JIANG Huiqin , WANG Beili , GUO Wei

Subjects: “…cancer| homologous recombination deficiency| poly (adp-ribose) polymerase inhibitor|precision therapy…”
Get full text

Colon-Targeted Poly(ADP-ribose) Polymerase Inhibitors Synergize Therapeutic Effects of Mesalazine Against Rat Colitis Induced by 2,4-Dinitrobenzenesulfonic Acid by Changyu Kang, Jaejeong Kim, Yeonhee Jeong, Jin-Wook Yoo, Yunjin Jung

Subjects: “…poly(ADP-ribose) polymerase inhibitor…”
Get full text

Combining Novel Hormonal Therapies with a Poly (ADP-Ribose) Polymerase Inhibitor for Metastatic Castration-Resistant Prostate Cancer: Emerging Evidence by Jie Yang, Xingyu Xiong, Weitao Zheng, Xinyang Liao, Hang Xu, Lu Yang, Qiang Wei

Subjects: “…poly (ADP-ribose) polymerase inhibitor…”
Get full text

Liquid chromatography-tandem mass spectrometry for pharmacokinetics evaluation of AZD5305, a selective PARP1 inhibitor, in mice by Gi Ju Lee, Jin Woo Kim, Hae-In Choi, Jin Young Choi, Kwan Hyung Cho, Tae-Sung Koo

Subjects: Get full text

Risk factors for the failure of first‐line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic Oncology Research Investigators Collaboration St... by Nam Kyeong Kim, Yeorae Kim, Hee Seung Kim, Soo Jin Park, Dong Won Hwang, Sung Jong Lee, Ji Geun Yoo, Suk‐Joon Chang, Joo‐Hyuk Son, Tae‐Wook Kong, Jeeyeon Kim, Seung‐Hyuk Shim, A Jin Lee, Dong Hoon Suh, Yoo‐Young Lee

Subjects: Get full text

Patient Assessment and Therapy Planning Based on Homologous Recombination Repair Deficiency by Wenbin Li, Lin Gao, Xin Yi, Shuangfeng Shi, Jie Huang, Leming Shi, Xiaoyan Zhou, Lingying Wu, Jianming Ying

Subjects: Get full text

Alteration of DNA Damage Response Causes Cleft Palate by Hiroyuki Yamaguchi, Kohei Kitami, Xiao Wu, Li He, Jianbo Wang, Bin Wang, Bin Wang, Yoshihiro Komatsu, Yoshihiro Komatsu

Subjects: Get full text

Targeted therapy and immunotherapy: Diamonds in the rough in the treatment of epithelial ovarian cancer by Xu Huang, Xu Huang, Xiao-Yu Li, Xiao-Yu Li, Wu-Lin Shan, Yao Chen, Qi Zhu, Bai-Rong Xia

Subjects: Get full text

Efficacy and safety of angiogenesis inhibitors combined with poly ADP ribose polymerase inhibitors in the maintenance treatment of advanced ovarian cancer: a meta-analysis by Renming Huang, Feng Ji, Leyi Huang, Yueying Qin, Zhiyu Liang, Miaoyan Huang, Chunyan Li, Jian Ban

Subjects: Get full text

Comparative efficacy of olaparib in combination with or without novel antiandrogens for treating metastatic castration-resistant prostate cancer by Xiangyu Chen, Yang Pan, Qihua Wang, Congzhe Ren, Muwei Li, Xuexue Hao, Lijun Xie, Xiaoqiang Liu

Subjects: Get full text

PARPi increases radiotherapy sensitivity of esophageal squamous cell carcinoma by inhibiting XRCC1 expression by LI Yiping, ZHANG Yufei, SUN Guangzhi, YE Yunyao, SHEN Xiaozhou, HAN Gaohua

Subjects: Get full text

Poly (ADP-Ribose) Polymerase Inhibitor Olaparib-Resistant <i>BRCA1</i>-Mutant Ovarian Cancer Cells Demonstrate Differential Sensitivity to PARP Inhibitor Rechallenge by Chi-Ting Shih, Tzu-Ting Huang, Jayakumar R. Nair, Kristen R. Ibanez, Jung-Min Lee

Subjects: “…poly (ADP-ribose) polymerase inhibitor resistance…”
Get full text

Cytotoxic Effects of Fascaplysin against Small Cell Lung Cancer Cell Lines by Gerhard Hamilton

Subjects: Get full text

Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline BRCA mutation? by Sabah Alaklabi, Arya Mariam Roy, Lubna N. Chaudhary, Shipra Gandhi

Subjects: Get full text

A comprehensive comparison of PARP inhibitors as maintenance therapy in platinum-sensitive recurrent ovarian cancer: a systematic review and network meta-analysis by Shiya Ji, Lu Chen, Yebo Yu, Xupeng Chen, Liwen Wei, Lili Gou, Cheng Shi, Susu Zhuang

Subjects: Get full text

PARP inhibitors are a new area in the treatment of breast cancer by V. P. Letyagin

Subjects: Get full text

PARP inhibitors as first-line maintenance therapy in ovarian cancer: recommendations from an expert panel from Brazil by Aknar FC Calabrich, Daniele Xavier Assad, Graziela Dal-Molin, Andreia C Melo, Angelica Nogueira-Rodrigues, Karime Kalil, Andrea PG Guimarães, Michelle Samora Almeida, Carla Rameri de Azevedo, Daniela de Freitas, Alessandra Menezes Morelle, Ana Carolina Leite, Marcela Crosara, João Soares Nunes, Poliana Signorini, Eduardo Cronemberger, Rachel Cossetti, Rodrigo Guindalini, Eduardo Paulino, Fernando C Maluf

Subjects: Get full text

PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: Unraveling the Therapeutic Landscape by Ashaar Al-Akhras, Chadi Hage Chehade, Arshit Narang, Umang Swami

Subjects: Get full text

Effect and Mechanism of Radiosensitization of Poly (ADP-Ribose) Polymerase 
Inhibitor on Lewis Cells and Xenografts by Wei WANG, Bixia DUAN, Li ZENG

Subjects: “…Poly (ADP -Ribose) polymerase inhibitors…”
Get full text